AstraZeneca Shares Voting Rights Update

AstraZeneca (AZN) has released an update.

AstraZeneca PLC, a leading biopharmaceutical company, announced that as of April 30, 2024, its issued share capital with voting rights totals 1,550,235,025 ordinary shares, which shareholders can use as a denominator for interest notifications. The company, known for its work in Oncology, Rare Diseases, and various other therapeutic areas, operates globally and is committed to the discovery and development of prescription medicines.

For further insights into AZN stock, check out TipRanks’ Stock Analysis page.